Research & Literature

Characteristics of gastrointestinal hemorrhage associated with pancreatic cancer: A retrospective review of 246 cases.

Wang YU, Yuan C, Liu X

Molecular and clinical oncology 2015; (3(4)):902-908 doi:10.3892/mco.2015.563.

Early decrement of serum carbohydrate antigen 19-9 predicts favorable outcome in advanced pancreatic cancer.

Chung KH, Ryu JK, Lee BS, et al.

Journal of gastroenterology and hepatology 2016; (31(2)):506-12 doi:10.1111/jgh.13075.

Comparison of Adverse Events for Endoscopic vs Percutaneous Biliary Drainage in the Treatment of Malignant Biliary Tract Obstruction in an Inpatient National Cohort.

Inamdar S, Slattery E, Bhalla R, et al.

JAMA oncology 2016; (2(1)):112-7 doi:10.1001/jamaoncol.2015.3670.

Management of pancreatic cancer in the elderly.

Higuera O, Ghanem I, Nasimi R, et al.

World journal of gastroenterology 2016; (22(2)):764-75 doi:10.3748/wjg.v22.i2.764.

What are the current and potential future roles for endoscopic ultrasound in the treatment of pancreatic cancer?

Oh SY, Irani S, Kozarek RA

World journal of gastrointestinal endoscopy 2016; (8(7)):319-29 doi:10.4253/wjge.v8.i7.319.

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.

Allen PJ, Kuk D, Castillo CF, et al.

Annals of surgery 2017; (265(1)):185-191 doi:10.1097/SLA.0000000000001763.

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Balaban EP, Mangu PB, Khorana AA, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(22)):2654-68 doi:10.1200/JCO.2016.67.5561.

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Khorana AA, Mangu PB, Berlin J, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(21)):2541-56 doi:10.1200/JCO.2016.67.5553.

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Sohal DP, Mangu PB, Khorana AA, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(23)):2784-96 doi:10.1200/JCO.2016.67.1412.

Acute Cholecystitis with Significantly Elevated Levels of Serum Carbohydrate Antigen 19-9.

Akimoto S, Banshodani M, Nishihara M, et al.

Case reports in gastroenterology 2016; (10(2)):410-416 doi:10.1159/000448068.

Management of Locally Advanced Pancreatic Cancer.

Martin RC

The Surgical clinics of North America 2016; (96(6)):1371-1389 doi:10.1016/j.suc.2016.07.010.

Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning.

Zaky AM, Wolfgang CL, Weiss MJ, et al.

Radiographics : a review publication of the Radiological Society of North America, Inc 2017; (37(1)):93-112 doi:10.1148/rg.2017160054.

A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.

Boursi B, Finkelman B, Giantonio BJ, et al.

Gastroenterology 2017; (152(4)):840-850.e3 doi:10.1053/j.gastro.2016.11.046.

Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.

Kim HW, Lee JC, Paik KH, et al.

Surgery 2017; (161(6)):1579-1587 doi:10.1016/j.surg.2016.12.038.

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.

Luo G, Liu C, Guo M, et al.

Annals of surgery 2017; (265(4)):800-805 doi:10.1097/SLA.0000000000001741.

Early detection of sporadic pancreatic cancer: time for change.

Frič P, Šedo A, Škrha J, et al.

European journal of gastroenterology & hepatology 2017; (29(8)):885-891 doi:10.1097/MEG.0000000000000904.

Negotiating the complexities of exocrine and endocrine dysfunction in chronic pancreatitis.

Duggan SN

The Proceedings of the Nutrition Society 2017; (76(4)):484-494 doi:10.1017/S0029665117001045.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, et al.

Journal of the National Comprehensive Cancer Network : JNCCN 2017; (15(8)):1028-1061 doi:10.6004/jnccn.2017.0131.

Diagnosis and management of pancreatic exocrine insufficiency.

Nikfarjam M, Wilson JS, Smith RC,

The Medical journal of Australia 2017; (207(4)):161-165 doi:10.5694/mja16.00851.

Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease.

Kim MS, Jeon TJ, Park JY, et al.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2017; (70(2)):96-102 doi:10.4166/kjg.2017.70.2.96.

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.

Zschaeck S, Blümke B, Wust P, et al.

PloS one 2017; (12(10)):e0186341 doi:10.1371/journal.pone.0186341.

Imaging mimics of pancreatic ductal adenocarcinoma.

Gandhi NS, Feldman MK, Le O, Morris-Stiff G

Abdominal radiology (New York) 2018; (43(2)):273-284 doi:10.1007/s00261-017-1330-1.

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.

Isaji S, Mizuno S, Windsor JA, et al.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2018; (18(1)):2-11 doi:10.1016/j.pan.2017.11.011.

Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis.

Wyse JM, Battat R, Sun S, et al.

Endoscopic ultrasound 2017; (6(6)):369-375 doi:10.4103/eus.eus_97_17.

Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?

He J, Blair AB, Groot VP, et al.

Annals of surgery 2018; (268(1)):1-8 doi:10.1097/SLA.0000000000002672.

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.

Hu ZI, Shia J, Stadler ZK, et al.

Clinical cancer research : an official journal of the American Association for Cancer Research 2018; (24(6)):1326-1336 doi:10.1158/1078-0432.CCR-17-3099.

Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimens.

Soer E, Brosens L, van de Vijver M, et al.

Virchows Archiv : an international journal of pathology 2018; (472(4)):533-543 doi:10.1007/s00428-018-2321-5.

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.

Brand R, Borazanci E, Speare V, et al.

Cancer 2018; (124(17)):3520-3527 doi:10.1002/cncr.31628.

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.

Luo G, Fan Z, Cheng H, et al.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2018; (18(8)):971-976 doi:10.1016/j.pan.2018.08.003.

Dilemma of elevated CA 19-9 in biliary pathology.

Tsen A, Barbara M, Rosenkranz L

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2018; (18(8)):862-867 doi:10.1016/j.pan.2018.09.004.

Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic Efficiency.

Parra-Robert M, Santos VM, Canis SM, et al.

Anticancer research 2018; (38(10)):5883-5888 doi:10.21873/anticanres.12931.

International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.

van Roessel S, Kasumova GG, Verheij J, et al.

JAMA surgery 2018; (153(12)):e183617 doi:10.1001/jamasurg.2018.3617.

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Conroy T, Hammel P, Hebbar M, et al.

The New England journal of medicine 2018; (379(25)):2395-2406 doi:10.1056/NEJMoa1809775.

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.

Singhi AD, George B, Greenbowe JR, et al.

Gastroenterology 2019; (156(8)):2242-2253.e4 doi:10.1053/j.gastro.2019.02.037.

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.

Murphy JE, Wo JY, Ryan DP, et al.

JAMA oncology 2019; (5(7)):1020-1027 doi:10.1001/jamaoncol.2019.0892.

Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.

Barkin JA, Westermann A, Hoos W, et al.

Pancreas 2019; (48(6)):780-786 doi:10.1097/MPA.0000000000001330.

RAS in pancreatic cancer.

Lanfredini S, Thapa A, O'Neill E

Biochemical Society transactions 2019; (47(4)):961-972 doi:10.1042/BST20170521.

Navigated magnetic resonance imaging-guided celiac plexus neurolysis using an open magnetic resonance system for pancreatic cancer patients with upper abdominal pain.

Jin G, Qiu X, Ding M, et al.

Journal of cancer research and therapeutics 2019; (15(4)):825-830 doi:10.4103/jcrt.JCRT_38_19.

Pancreatic Enzyme Replacement Therapy: A Concise Review.

Brennan GT, Saif MW

JOP : Journal of the pancreas 2019; (20(5)):121-125.

White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.

Kulkarni NM, Soloff EV, Tolat PP, et al.

Abdominal radiology (New York) 2020; (45(3)):716-728 doi:10.1007/s00261-019-02289-5.

Pancreatic Neoplasms With Acinar Differentiation: A Review of Pathologic and Molecular Features.

Thompson ED, Wood LD

Archives of pathology & laboratory medicine 2020; (144(7)):808-815 doi:10.5858/arpa.2019-0472-RA.

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer.

Pezzilli R, Caccialanza R, Capurso G, et al.

Cancers 2020; (12(2)) doi:10.3390/cancers12020275.

An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.

Rainone M, Singh I, Salo-Mullen EE, et al.

JAMA oncology 2020; (6(5)):764-771 doi:10.1001/jamaoncol.2019.5963.

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.

Versteijne E, Suker M, Groothuis K, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(16)):1763-1773 doi:10.1200/JCO.19.02274.

Pancreatic Cancer and Its Microenvironment-Recent Advances and Current Controversies.

Stopa KB, Kusiak AA, Szopa MD, et al.

International journal of molecular sciences 2020; (21(9)) doi:10.3390/ijms21093218.

Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous interventions.

Tavakkoli A, Elmunzer BJ, Waljee AK, et al.

Gastrointestinal endoscopy 2021; (93(1)):154-162.e5 doi:10.1016/j.gie.2020.05.061.

Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis.

Iglesia D, Avci B, Kiriukova M, et al.

United European gastroenterology journal 2020; (8(9)):1115-1125 doi:10.1177/2050640620938987.

Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils.

Schawkat K, Manning MA, Glickman JN, Mortele KJ

Radiographics : a review publication of the Radiological Society of North America, Inc 2020; (40(5)):1219-1239 doi:10.1148/rg.2020190184.

Defining and Treating Borderline Resectable Pancreatic Cancer.

Perri G, Prakash L, Katz MHG

Current treatment options in oncology 2020; (21(9)):71 doi:10.1007/s11864-020-00769-1.

Clinical outcome of a highly flexible duodenal stent for gastric outlet obstruction: A multicenter prospective study.

Miwa H, Sugimori K, Kaneko T, et al.

JGH open : an open access journal of gastroenterology and hepatology 2020; (4(4)):729-735 doi:10.1002/jgh3.12326.

One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches.

Niger M, Prisciandaro M, Antista M, et al.

World journal of gastrointestinal oncology 2020; (12(8)):833-849 doi:10.4251/wjgo.v12.i8.833.

Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.

Petrusel L, Bilibou M, Drug V, et al.

Journal of gastrointestinal and liver diseases : JGLD 2020; (29(3)):391-398 doi:10.15403/jgld-2529.

Use of imaging as staging and surgical planning for pancreatic surgery.

Nguyen AH, Melstrom LG

Hepatobiliary surgery and nutrition 2020; (9(5)):603-614 doi:10.21037/hbsn.2019.05.04.

Malignant epithelial/exocrine tumors of the pancreas.

Luchini C, Grillo F, Fassan M, et al.

Pathologica 2020; (112(3)):210-226 doi:10.32074/1591-951X-167.

Continuous Glucose Monitoring for the Detection of Hypoglycemia in Patients With Diabetes of the Exocrine Pancreas.

Shivaprasad C, Gautham K, Shah K, et al.

Journal of diabetes science and technology 2021; (15(6)):1313-1319 doi:10.1177/1932296820974748.

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.

Kunzmann V, Siveke JT, Algül H, et al.

The lancet. Gastroenterology & hepatology 2021; (6(2)):128-138 doi:10.1016/S2468-1253(20)30330-7.

Endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) technique and analgesic efficacy in patients with pancreatic cancer: A systematic review and meta-analysis.

Koulouris AI, Alexandre L, Hart AR, Clark A

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2021; (21(2)):434-442 doi:10.1016/j.pan.2020.12.016.

Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer.

Bevins J, Bhulani N, Goksu SY, et al.

American journal of clinical oncology 2021; (44(5)):181-186 doi:10.1097/COC.0000000000000802.

The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine.

Bispo M, Marques S, Rio-Tinto R, et al.

GE Portuguese journal of gastroenterology 2021; (28(2)):111-120 doi:10.1159/000509197.

Burden of venous thromboembolism in patients with pancreatic cancer.

Frere C

World journal of gastroenterology 2021; (27(19)):2325-2340 doi:10.3748/wjg.v27.i19.2325.

How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.

Jeon SK, Lee JM, Lee ES, et al.

European radiology 2022; (32(1)):56-66 doi:10.1007/s00330-021-08108-0.

Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced, Unresectable Pancreatic Cancer: A Multicenter Observational Study (NAPOLEON Study).

Arima S, Kawahira M, Shimokawa M, et al.

Pancreas 2021; (50(7)):957-964 doi:10.1097/MPA.0000000000001859.

Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Verbeke C, Webster F, Brosens L, et al.

Histopathology 2021; (79(6)):902-912 doi:10.1111/his.14540.

Targeting DNA damage repair pathways in pancreas cancer.

Crowley F, Park W, O'Reilly EM

Cancer metastasis reviews 2021; (40(3)):891-908 doi:10.1007/s10555-021-09983-1.

Treatment of type 2 diabetes mellitus and risk of pancreatic cancer.

Olakowska E, Olakowski M

Endokrynologia Polska 2021; (72(4)):395-401 doi:10.5603/EP.a2021.0069.

Pancreatic Cancer: A Review.

Park W, Chawla A, O'Reilly EM

JAMA 2021; (326(9)):851-862 doi:10.1001/jama.2021.13027.

Endoscopic ultrasonography-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer: An update.

Pérez-Aguado G, de la Mata DM, Valenciano CM, Sainz IF

World journal of gastrointestinal endoscopy 2021; (13(10)):460-472 doi:10.4253/wjge.v13.i10.460.

Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes.

Emelyanova M, Pudova E, Khomich D, et al.

Therapeutic advances in medical oncology 2022; (14()):17588359221083050 doi:10.1177/17588359221083050.

Gastric Perforation: A Rare Presentation of Malignant Gastric Outlet Obstruction.

Silangruz K, Shah P, Fujii-Lau L, Furuta S

Cureus 2022; (14(2)):e22242 doi:10.7759/cureus.22242.

Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature.

Xu JY, Guan WL, Lu SX, et al.

Clinical Medicine Insights. Oncology 2022; (16()):11795549221090186 doi:10.1177/11795549221090186.

The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing.

Walker EJ, Blanco AM, Carnevale J, et al.

Pancreas 2022; (51(4)):302-304 doi:10.1097/MPA.0000000000002021.

Systematic review and meta-analysis of celiac plexus neurolysis for abdominal pain associated with unresectable pancreatic cancer.

Okita M, Otani K, Gibo N, Matsui S

Pain practice : the official journal of World Institute of Pain 2022; (22(7)):652-661 doi:10.1111/papr.13143.

Defining the rate of nutritional and metabolic derangements after pancreatic resection.

Percy KL, Ooi YX, Nahm CB, et al.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2022; (22(7)):1028-1034 doi:10.1016/j.pan.2022.07.014.

The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.

Mohindroo C, De Jesus-Acosta A, Yurgelun MB, et al.

Surgical pathology clinics 2022; (15(3)):491-502 doi:10.1016/j.path.2022.05.004.

Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer.

Kang H, Kim SS, Sung MJ, et al.

Cancers 2022; (14(19)) doi:10.3390/cancers14194672.

Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis.

Mellenthin C, Balaban VD, Dugic A, Cullati S

Cancers 2022; (14(19)) doi:10.3390/cancers14194684.

The connection between innervation and metabolic rearrangements in pancreatic cancer through serine.

Dong M, Cao L, Cui R, Xie Y

Frontiers in oncology 2022; (12()):992927 doi:10.3389/fonc.2022.992927.

Novel Insights Into Immunohistochemical Analysis For Acinar Cell Neoplasm of The Pancreas: Carboxypeptidase A2, Carboxypeptidase A1, and Glycoprotein 2.

Ishimoto-Namiki U, Ino Y, Esaki M, et al.

The American journal of surgical pathology 2023; (47(5)):525-534 doi:10.1097/PAS.0000000000002024.

EUS-guided fine needle biopsy is able to provide diagnosis in rare osteoclast-like giant cells undifferentiated carcinoma of the pancreas: report of two cases.

Pop RM, Diaconu CI, Rimbaş M, et al.

Romanian journal of internal medicine = Revue roumaine de medecine interne 2023; (61(2)):116-124 doi:10.2478/rjim-2023-0008.

The impact of early palliative care on the quality of life of patients with advanced pancreatic cancer: The IMPERATIVE case-crossover study.

Kim CA, Lelond S, Daeninck PJ, et al.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2023; (31(4)):250 doi:10.1007/s00520-023-07709-3.

EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting.

Vanella G, Dell'Anna G, Capurso G, et al.

Gastrointestinal endoscopy 2023; (98(3)):337-347.e5 doi:10.1016/j.gie.2023.04.2072.

Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort.

Taïeb J, Sayah L, Heinrich K, et al.

European journal of cancer (Oxford, England : 1990) 2023; (188()):90-97 doi:10.1016/j.ejca.2023.04.012.

Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.

Florou V, Elliott A, Bailey MH, et al.

Clinical cancer research : an official journal of the American Association for Cancer Research 2023; (29(17)):3408-3417 doi:10.1158/1078-0432.CCR-22-3724.

Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.

Mandelker D, Marra A, Zheng-Lin B, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023; (41(33)):5151-5162 doi:10.1200/JCO.23.00561.

AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review.

Whitcomb DC, Buchner AM, Forsmark CE

Gastroenterology 2023; (165(5)):1292-1301 doi:10.1053/j.gastro.2023.07.007.

Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.

Lewis DM, Rieke JG, Almusaylim K, et al.

Digestive diseases and sciences 2024; (69(2)):615-633 doi:10.1007/s10620-023-08184-w.

Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer.

LaRose M, Manji GA, Bates SE

Seminars in oncology 2024; (51(1-2)):36-44 doi:10.1053/j.seminoncol.2023.11.001.

Imaging of pancreatic ductal adenocarcinoma - An update for all stages of patient management.

Bilreiro C, Andrade L, Santiago I, et al.

European journal of radiology open 2024; (12()):100553 doi:10.1016/j.ejro.2024.100553.

Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data.

Shouman MA, Fuchs F, Walter F, et al.

Clinical and translational radiation oncology 2024; (45()):100738 doi:10.1016/j.ctro.2024.100738.

Palliative Stenting for Gastric Outlet Obstruction Secondary to Pancreatic Adenocarcinoma.

Patel D, Bhullar FA, Tagliaferri AR, et al.

Cureus 2024; (16(1)):e53186 doi:10.7759/cureus.53186.

Surgical Palliation for Advanced Pancreas Cancer.

Jacobs CS, Vitello DJ, Chawla A

The Surgical clinics of North America 2024; (104(5)):1121-1135 doi:10.1016/j.suc.2024.04.008.

Consensus, debate, and prospective on pancreatic cancer treatments.

Wang J, Yang J, Narang A, et al.

Journal of hematology & oncology 2024; (17(1)):92 doi:10.1186/s13045-024-01613-x.

Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry.

Schuhbaur J, Surovtsova I, Seufferlein T, et al.

BMC cancer 2024; (24(1)):1280 doi:10.1186/s12885-024-12995-z.

Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma.

Blair AB, Radomski SN, Chou J, et al.

Annals of surgical oncology 2025; (32(3)):1869-1878 doi:10.1245/s10434-024-16331-4.

Palliative Care and End-of-Life Care in Metastatic Pancreatic Cancer.

O'Brien J, Halsey B, Connors M, et al.

Journal of palliative medicine 2025; (28(2)):217-223 doi:10.1089/jpm.2024.0313.

Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fusion events.

Delgado-de la Mora J, Al Assaad M, Karaaslan S, et al.

Pathology, research and practice 2025; (266()):155798 doi:10.1016/j.prp.2024.155798.

Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis.

Dickerson LD, Gittens J, Brunning C, et al.

BJS open 2025; (9(2)) doi:10.1093/bjsopen/zrae172.

The Brazilian Society of Surgical Oncology (SBCO) Guidelines for the Treatment of Exocrine Pancreatic Insufficiency in Cancer Patients.

Pinheiro RN, Coutinho AK, Filho PEP, et al.

Journal of surgical oncology 2025; (132(1)):88-94 doi:10.1002/jso.28162.

Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgroup Analysis of the NORPACT-2 Trial.

Ghotbi J, Farnes I, Kleive D, et al.

Annals of surgical oncology 2025; (32(12)):8856-8869 doi:10.1245/s10434-025-17527-y.

Diagnosis and treatment strategies for hereditary pancreatic cancer syndrome.

Matsubayashi H, Morizane C, Kanai M, et al.

International journal of clinical oncology 2025; doi:10.1007/s10147-025-02905-z.

Updates and Review of Neoadjuvant Therapy for Resectable Pancreatic Cancer.

Cobb W, Rozefort D, Ji C, et al.

Oncology 2026; (104(6)):663-671 doi:10.1159/000548583.

Approach to the Patient with Pancreatogenic Diabetes.

Ode KL, Imai Y, Norris AW

The Journal of clinical endocrinology and metabolism 2025; doi:10.1210/clinem/dgaf623.

Germline Mutations in DNA Repair Genes in Patients with Pancreatic Neuroendocrine Neoplasms: Diagnostic and Therapeutic Implications.

Jurecka-Lubieniecka B, Ros-Mazurczyk M, Sygula A, et al.

Current oncology (Toronto, Ont.) 2025; (32(11)) doi:10.3390/curroncol32110631.

KRAS-Wild Pancreatic Cancer-More Targets than Treatment Possibilities?

Krupa K, Fudalej M, Miski H, et al.

Cancers 2025; (17(23)) doi:10.3390/cancers17233769.

Diagnosis and Surgical Management for Advanced Pancreatic Cancer Requiring Vascular Resection.

Symeou S, Lolis ED, Glantzounis GK

Diagnostics (Basel, Switzerland) 2025; (16(1)) doi:10.3390/diagnostics16010102.

[Pancreatic acinar cell carcinoma: Clinical and theranostic characteristics].

Marques A, Mas L, Dardenne A, et al.

Bulletin du cancer 2026; (113(6)):806-815 doi:10.1016/j.bulcan.2026.01.007.

Diabetes secondary to chronic pancreatitis and pancreatic cancer: Observations from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Hart PA, Andersen DK, Bellin MD, et al.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2026; (26(4)):581-586 doi:10.1016/j.pan.2026.04.001.

Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma.

Faghih M, Damm M, Gutzler C, et al.

Journal of gastroenterology 2026; doi:10.1007/s00535-026-02423-3.

Clinical Outcomes and Complications of Endoscopic Biliary Stenting for Malignant Distal Biliary Obstruction in Pancreatic Cancer: A Systematic Review.

Abdiyev N, Jaxymbayev N, Maira M, et al.

Journal of clinical medicine 2026; (15(8)) doi:10.3390/jcm15083126.

Pain management in pancreatic cancer: time to change our strategy!

Blero D, Hendlisz A

Current opinion in oncology 2026; (38(4)):359-363 doi:10.1097/CCO.0000000000001251.

Updates on Imaging Assessment of Pancreatic Cancer for Determining Anatomic and Biologic Resectability.

Lee SS, Kim DW, Lee W, Kim KP

Korean journal of radiology 2026; (27(7)):634-651 doi:10.3348/kjr.2026.0341.

Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanced pancreatic adenocarcinoma: a multicentre propensity-matched study.

Thambamroong T, Meesart R, Prasongsook N, et al.

BMJ oncology 2026; (5(2)):e001085 doi:10.1136/bmjonc-2026-001085.

Pancreatic Acinar Cell Carcinoma: A Rare Pancreatic Malignancy with Distinct Biology and Emerging Therapeutic Opportunities.

Farhoud N, Al-Rajabi RMT, Baranda JC, et al.

Cancers 2026; (18(14)) doi:10.3390/cancers18142315.